ACR CT Accreditation Program and the Lung Cancer Screening Program Designation

详细信息    查看全文

• 作者：Ella A. Kazerooni ; MD ; MS^a ; ^{ellakaz@umich.edu" class="auth_mail" title="E-mail the corresponding author} ; Mark R. Armstrong ; MD^b ; Judith K. Amorosa ; MD^c ; Dina Hernandez ; BSRT ; RT(R)(CT)(QM)^d ; Lawrence A. Liebscher ; MD^e ; Hrudaya Nath ; MD^f ; Michael F. McNitt-Gray ; PhD^g ; Eric J. Stern ; MD^h ; Pamela A. Wilcox ; RN ; MBAⁱ
• 刊名：Journal of the American College of Radiology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：13
• 期：2_supp_S
• 页码：R30-R34
• 全文大小：101 K

文摘

The ACR recognizes that low-dose CT for lung cancer screening has the potential to significantly reduce mortality from lung cancer in the appropriate high-risk population. The ACR supports the recommendations of the US Preventive Services Task Force and the National Comprehensive Cancer Network for screening patients. To be effective, lung cancer screening should be performed at sites providing high-quality low-dose CT examinations overseen and interpreted by qualified physicians using a structured reporting and management system. The ACR has developed a set of tools necessary for radiologists to take the lead on the front lines of lung cancer screening. The ACR Lung Cancer Screening Center designation is built upon the ACR CT accreditation program and requires use of Lung-RADS or a similar structured reporting and management system. This designation provides patients and referring providers with the assurance that they will receive high-quality screening with appropriate follow-up care.